The Institute for Clinical and Translational Science at the University of Iowa has won $6.9 million to continue academic, educational, and research programs for researchers throughout the university.

The grant from the National Institutes of Health is the second Clinical and Translational Science Award received by the UI. It will allow the ICTS to continue offering research resources and training, services, pilot grant funding, and educational opportunities to UI investigators.

Gary Rosenthal

“We will continue to provide a state-of-the-art physical infrastructure in which to conduct clinical research as well as expert personnel and consultants to support investigators as they design, implement, and disseminate their studies,” said Gary Rosenthal, the ICTS director and the principal investigator on the grant.

Clinical and translational science improves health through innovation and discovery in four main areas:

• Translating basic science research to humans
• Testing new treatments and interventions
• Applying research recommendations and guidelines to clinical practice
• Developing new policies to benefit populations

Also as part of the grant, the ICTS will continue its five-year partnership with the Clinical and Translational Science Award consortium. The consortium consists of 60 institutions committed to improving human health by streamlining scientific procedures, transforming training environments, and improving the conduct, quality, and dissemination of clinical and translational research.

The ICTS includes scientists and academics from the UI’s eleven colleges as well as researchers participating in the Clinical and Translational Science Award program, which is led by the National Center for Advancing Translational Sciences, part of the National Institutes of Health.